Current Committee Members (2017/18)
Chairperson: John Michael Morris (formerly HPRA)
Michael obtained a degree in Pharmacy and PhD from the University of Manchester and worked briefly in industry in the UK. He then worked as a QA pharmacist in a number of hospital based manufacturing plants in the UK over the next 10 years. In 1987, he moved to Ireland to work for NDAB/IMB/HPRA and became Director Scientific Affairs at the Health Products Regulatory Authority (HPRA) of Ireland in 2004 until he retired at the end of 2015. Michael was formerly Pharmaceutical Director, IMB, responsible for the assessment of quality data (CMC data) and before that Senior Pharmacist at the Irish National Drugs Advisory Board. Dr. Morris was the EU member of the ICH Q6A Expert Working Group, and subsequently became EU topic leader and then Chair of ICH Q4B -pharmacopoeial harmonisation. In 2004 he was elected to the position of Chairman of the European Pharmacopoeia Commission until 2007 and he remained a member of the Ph. Eur.Commission until 2016. He is Chair of Ph. Eur. Working Party PAT and a member of Group 12, pharmaceutical dose forms. He has also served on a number of committees of PSI, Steering Committee of IIOP and the dissolution testing focus group of FIP. He has also been very active in the Ireland chapter of PDA since its inception in 2006 and has just recently stepped down after two years as President of that organization.
Secretary: Laura Daly (QM Specials)
Laura is working in QA with QM Specials in Lismore, Co. Waterford since October 2017. She graduated with a degree in Pharmacy from University College Cork in 2016 before completing her internship in the Pharmaceutical Assessment section of the HPRA in and in Lloyds Pharmacy. Laura has previously worked in Technical Operations with AbbVie, IMS Health (now IQVIA) and the Health Information Systems Research Centre in University College Cork.
Treasurer: Peter Twomey (HPRA)
Peter joined the Health Products Regulatory Authority (HPRA) in July 2017 as Good Clinical Practice & Pharmacovigilance Inspector. Prior to joining the HPRA, he held various positions including the position of pharmacovigilance inspector with the MHRA (the UK medicines regulator) and qualified person for pharmacovigilance (QPPV) and pharmacovigilance manager in industry. He holds a Master of Pharmacy degree from RCSI.
Gwynne Morley (Mater Private)
Gwynne is the Director of Heart & Vascular, Diabetes & Emergency Department at the Mater Private. She is the former Managing Director at Uniphar Retail Services division. She has extensive experience and knowledge of the pharmaceutical industry, from the manufacturer to the patient. Previously she worked for United Drug Group (UDG) Healthcare for 13 years where she was a member of the Senior Executive team. During her tenure with UDG, she held a number of senior roles namely in pre-wholesale, consumer, homecare and quality. Prior to joining UDG, she held management positions within the Crowley Retail Pharmacy Chain and held a multifunctional role within the medical department of Zeneca Pharma, Ireland. She is a graduate of TCD. Gwynne is a outgoing Chairperson of PIER (2014-2017).
Helen Naddy (Mallinckrodt)
Helen brings a diverse range of experience to the PIER committee. Since graduating, she has worked in a number of quality focused roles. Building on experience gained in Medisource, specializing in the distribution of named-patient medicines, she relocated to London to take on a role within the European Medicines Agency (EMA). She returned to Dublin in June 2014, joining the Quality team at Mallinckrodt and is involved in dealing with all matters relating to quality both domestically and internationally. In addition, she regularly works as a locum community pharmacist in order to keep up to date with changes in the industry. Helen is a former Secretary of PIER (2014-2017).
Maura Kinahan (formerly Pfizer)
Maura has spent most of her career to-date in various roles in the pharmaceutical industry (Pharmaceutical Development, Regulatory Affairs, Supply Chain, Commercial, Medical Affairs) with Élan, Bristol-Myers Squibb & Pfizer. In 2014/15, she participated in the BioInnovate Fellowship programme, a specialist medical device innovation training programme based in NUI Galway. She holds a pharmacy degree from the University of Strathclyde, Glasgow and PhD from the University of Manchester. She is a founding member of PIER. She is currently on maternity leave.
Katie Ryan (School of Pharmacy, UCC)
Katie is currently a lecturer in Pharmaceutics in the School of Pharmacy, University College Cork. She graduated with a degree in Pharmacy from TCD. Upon completion of her pre-registration training (Élan Corporation and Waterford Regional Hospital), she went on to pursue a PhD in Pharmaceutics with Prof. Pat Deasy in the School of Pharmacy, TCD. In the School of Pharmacy, Cork she teaches both undergraduate and postgraduate courses in the areas of formulation science, novel drug delivery systems and statistics. Her research interests centre on next-generation medical devices to address device-related infection and bone regeneration strategies. In 2013 & 2014, she spent her sabbatical leave in Prof. David Mooney’s Bioengineering lab in Harvard University researching novel biomaterial strategies to promote bone tissue regeneration.
Evin Allen (Sanofi)
Evin graduated from UCC in 2011 before undertaking pre-registration training in research and hospital settings. In 2015, he graduated from UCC with a PhD in pharmaceutics/ pharmacology under Dr Abina Crean. He also undertook a post doc working with the SSPC investigating the impact of excipient variability on manufacturing. He joined Sanofi Waterford in 2016 has worked across a number of technical roles. Evin continues to Locum with a particular interest in opioid addiction services. In 2015, he founded an online e-commerce medical website and has a passion for innovation and entrepreneurship.
Peter O'Donnell (HPRA)
Peter is currently working as a Scientific Officer for Pharmacovigilance within the Human Products Monitoring (HPM) department at the HPRA. He studied Pharmacy at RCSI for both his BSc (Pharm) and MPharm, graduating in 2015. During his MPharm he was a Research Assistant in the Tissue Engineering Research Group (TERG). After his MPharm he returned to the TERG as a Deputy Project Manager of an in-vivo trial for a commercialisation project. Peter has also worked as a community pharmacist with Lloyds Pharmacy group as well as locum agencies.
Jack Daly (QuintilesIMS/IQVIA)
Jack no longer sits on the PIER committee but continues to represent PIER on the IIOP Steering Group.
Past Committee Members (2012-2017)
- Stan O’Neill (Compliance Group): Chairperson 2012-2014
- Mary Rafter (HPRA): Secretary 2012-2014
- Muireann McAlister (Pfizer, formerly AstraZeneca): Communications 2012-2014
- Jack Daly (QuintilesIMS/IQVIA formerly Grünenthal): 2012-2014
- Orlaith Brennan (IPHA): 2012-2013
- Brendan Griffin (UCC):Treasurer 2012-2015
- David Carroll (J&J DePuy, formerly PEI Medial): 2013-2015
- Michael Lennon (Alexion, formerly HPRA): Communications 2014-2016
- Catherine McHugh (PAREXEL, formerly HPRA): Membership 2012-2014
- Jenny Loughney (Novartis, formerly PharmaChemical Ireland): 2014-2015
- Rosemarie Tully (Neuromod, formerly Sigmoid Pharma): 2012-2016
- Cathal Gallagher (Mylan Respiratory): 2014-2017, Treasurer 2015-2017
- Vanessa Lyons (HPRA): 2015-2017
- Olivia Murphy (Bayer, formerly QuintilesIMS): 2015-2017
- Ita Walsh (Compliance Group): 2015-2017
- Barry O’Hea (LEO Pharma): 2016-2017